A Biomathematical Model of Pneumococcal Lung Infection and Antibiotic Treatment in Mice

PLoS One. 2016 May 19;11(5):e0156047. doi: 10.1371/journal.pone.0156047. eCollection 2016.

Abstract

Pneumonia is considered to be one of the leading causes of death worldwide. The outcome depends on both, proper antibiotic treatment and the effectivity of the immune response of the host. However, due to the complexity of the immunologic cascade initiated during infection, the latter cannot be predicted easily. We construct a biomathematical model of the murine immune response during infection with pneumococcus aiming at predicting the outcome of antibiotic treatment. The model consists of a number of non-linear ordinary differential equations describing dynamics of pneumococcal population, the inflammatory cytokine IL-6, neutrophils and macrophages fighting the infection and destruction of alveolar tissue due to pneumococcus. Equations were derived by translating known biological mechanisms and assuming certain response kinetics. Antibiotic therapy is modelled by a transient depletion of bacteria. Unknown model parameters were determined by fitting the predictions of the model to data sets derived from mice experiments of pneumococcal lung infection with and without antibiotic treatment. Time series of pneumococcal population, debris, neutrophils, activated epithelial cells, macrophages, monocytes and IL-6 serum concentrations were available for this purpose. The antibiotics Ampicillin and Moxifloxacin were considered. Parameter fittings resulted in a good agreement of model and data for all experimental scenarios. Identifiability of parameters is also estimated. The model can be used to predict the performance of alternative schedules of antibiotic treatment. We conclude that we established a biomathematical model of pneumococcal lung infection in mice allowing predictions regarding the outcome of different schedules of antibiotic treatment. We aim at translating the model to the human situation in the near future.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Load
  • Dose-Response Relationship, Drug
  • Mice
  • Models, Theoretical*
  • Pneumonia, Pneumococcal / drug therapy
  • Pneumonia, Pneumococcal / immunology
  • Pneumonia, Pneumococcal / microbiology*

Substances

  • Anti-Bacterial Agents

Grants and funding

This research was carried out in the project “Integrative Analysis and Biomathematical Modelling of Systemic Inflammation” within the research consortium “Medical Systems Biology of Pulmonary Barrier Failure in Community Acquired Pneumonia” (CAPSyS), managed by the project management agency DLR-PT. This research was funded by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (grant number 01ZX1304B). The authors acknowledge support from the German Research Foundation (DFG) and University of Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.